DAA and Treatment Resistant Hepatitis C

grazoprevir generic harvoni hepcnat lp hepcinat sunny pharma care exim soul of healing usa and india

  • Populations with genotype 1 and 3 are more likely to have cirrhosis and failure with peg alpha interferon treatments.
  • New study has effective treatment options for patients resistant to DAA and interferon previous treatments.
  • The treatments included were grazoprevir 100mg, ruzasvir 60mg and uprifosbuvir 450mg.
  • The hepatitis C treatments for patients that were not receptive previously were treated successfully.
  • Studies will be continued until there is a conclusive and 100% effective treatment for treatment resistant hepatitis C patients.